Gyre Therapeutics, Inc. Common Stock (GYRE) is a publicly traded Healthcare sector company. As of October 22, 2026, GYRE trades at $5.86 with a market cap of $625.60M and a P/E ratio of 118.67. GYRE moved -0.85% today. Year to date, GYRE is -13.36%; over the trailing twelve months it is -29.09%. Its 52-week range spans $5.44 to $13.75. Analyst consensus is buy with an average price target of $19.00. Rallies surfaces GYRE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for GYRE shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $5.86 |
| Market Cap | $625.60M |
| P/E Ratio | 118.67 |
| EPS | $0.06 |
| Dividend Yield | 0.24% |
| 52-Week High | $13.75 |
| 52-Week Low | $5.44 |
| Volume | 54.45K |
| Avg Volume | 0 |
| Revenue (TTM) | $116.59M |
| Net Income | $9.88M |
| Gross Margin | 95.36% |
2 analysts cover GYRE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $19.00.